| Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a … Task Force Members, GYH Lip, S Windecker, K Huber, P Kirchhof, ... European heart journal 35 (45), 3155-3179, 2014 | 675 | 2014 |
| Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting GYH Lip, K Huber, F Andreotti, H Arnesen, KJ Airaksinen, T Cuisset, ... Thrombosis and haemostasis 103 (01), 13-28, 2010 | 396 | 2010 |
| Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation: implications for … JM Ruiz-Nodar, F Marín, JA Hurtado, J Valencia, E Pinar, J Pineda, ... Journal of the American College of Cardiology 51 (8), 818-825, 2008 | 348 | 2008 |
| Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting F Marín, DA Pascual, V Roldán, JM Arribas, M Ahumada, PL Tornel, ... The American journal of cardiology 97 (1), 55-60, 2006 | 326 | 2006 |
| Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy L Monserrat, JR Gimeno-Blanes, F Marín, M Hermida-Prieto, ... Journal of the American College of Cardiology 50 (25), 2399-2403, 2007 | 325 | 2007 |
| Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary—a Consensus Document … GYH Lip, K Huber, F Andreotti, H Arnesen, JK Airaksinen, T Cuisset, ... European heart journal 31 (11), 1311-1318, 2010 | 322 | 2010 |
| Screening for atrial fibrillation: a European heart rhythm association (EHRA) consensus document endorsed by the heart rhythm Society (HRS), Asia Pacific heart rhythm Society … GH Mairesse, P Moran, IC Van Gelder, C Elsner, M Rosenqvist, J Mant, ... Ep Europace 19 (10), 1589-1623, 2017 | 318 | 2017 |
| Bleeding risk assessment and management in atrial fibrillation patients GYH Lip, F Andreotti, L Fauchier, K Huber, E Hylek, E Knight, D Lane, ... Thrombosis and haemostasis 106 (12), 997-1011., 2011 | 306 | 2011 |
| 2018 joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing … GYH Lip, JP Collet, M Haude, R Byrne, EH Chung, L Fauchier, ... Ep Europace 21 (2), 192-193, 2019 | 303 | 2019 |
| Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a “real-world” population with atrial fibrillation receiving anticoagulant therapy V Roldán, F Marín, H Fernández, S Manzano-Fernandez, P Gallego, ... Chest 143 (1), 179-184, 2013 | 280 | 2013 |
| Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of … GYH Lip, F Andreotti, L Fauchier, K Huber, E Hylek, E Knight, DA Lane, ... Europace 13 (5), 723-746, 2011 | 259 | 2011 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 246 | 2019 |
| The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial … V Roldán, F Marín, S Manzano-Fernández, P Gallego, JA Vílchez, ... Journal of the American College of Cardiology 62 (23), 2199-2204, 2013 | 245 | 2013 |
| Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome E Tortosa-Caparrós, D Navas-Carrillo, F Marín, E Orenes-Piñero Critical reviews in food science and nutrition 57 (16), 3421-3429, 2017 | 244 | 2017 |
| Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC working group … C Sticherling, F Marin, D Birnie, G Boriani, H Calkins, GA Dan, M Gulizia, ... Ep Europace 17 (8), 1197-1214, 2015 | 243 | 2015 |
| Soluble E-selectin in cardiovascular disease and its risk factors V Roldán, F Marín, GYH Lip, AD Blann Thrombosis and haemostasis 90 (12), 1007-1020, 2003 | 227 | 2003 |
| Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation P Gallego, V Roldan, F Marín, M Romera, M Valdés, V Vicente, GYH Lip Thrombosis and haemostasis 110 (12), 1189-1198, 2013 | 219 | 2013 |
| Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation V Roldán, F Marín, AD Blann, A García, P Marco, F Sogorb, GYH Lip European heart journal 24 (14), 1373-1380, 2003 | 193 | 2003 |
| Stroke and Thromboembolism in Atrial Fibrillation–Systematic Review of Stroke Risk Factors and Risk Stratification Schema– R Pisters, DA Lane, F Marin, AJ Camm, GYH Lip Circulation journal 76 (10), 2289-2304, 2012 | 192 | 2012 |
| Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation P Gallego, V Roldán, JM Torregrosa, J Gálvez, M Valdés, V Vicente, ... Circulation: Arrhythmia and Electrophysiology 5 (2), 312-318, 2012 | 186 | 2012 |
Vanessa Roldán (ORCID: 0000-0002-...Profesor Titular de Hematologia. Universidad de MurciaVerified email at um.es
